Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nawrocki, ST"'
Autor:
Carew JS; University of Arizona Cancer Center and Department of Medicine, Division of Translational and Regenerative Medicine, University of Arizona, Tucson, AZ, USA., Espitia CM; Division of Hematology/Oncology, Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Zhao W; Division of Hematology/Oncology, Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Mita MM; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Mita AC; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Nawrocki ST; University of Arizona Cancer Center and Department of Medicine, Division of Translational and Regenerative Medicine, University of Arizona, Tucson, AZ, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 Sep 30; Vol. 8 (49), pp. 86769-86783. Date of Electronic Publication: 2017 Sep 30 (Print Publication: 2017).
Autor:
Patel S; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Hurez V; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Nawrocki ST; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Goros M; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Michalek J; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Sarantopoulos J; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Curiel T; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Mahalingam D; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Publikováno v:
Oncotarget [Oncotarget] 2016 Sep 13; Vol. 7 (37), pp. 59087-59097.
Autor:
Kelly KR; Anne Nohl Division of Hematology and Center for The Study of Blood Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA, USA., Espitia CM; Department of Medicine and The Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, TX, USA., Zhao W; Department of Medicine and The Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, TX, USA., Wendlandt E; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Tricot G; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Zhan F; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Carew JS; Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Nawrocki ST; Department of Medicine and The Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center, San Antonio, TX, USA.
Publikováno v:
Oncotarget [Oncotarget] 2015 Dec 01; Vol. 6 (38), pp. 41275-89.